Evidence map›Paper›PMID 42488416›Full record

ReviewFrontiers in cellular and infection microbiology2026

Bacteriophage therapy beyond antibiotics: emerging innovations for infectious and non-infectious diseases.

Biyi Zhang, Xutong Shu, Abdullah Ibna Masud, Joyoshrie Karmakar, Jie Fan, Ishatur Nime, Mrityunjoy Acharjee, Fan Pan, Md Sharifull Islam

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Biyi Zhang *Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, China.
Xutong Shu *Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, China.
Abdullah Ibna MasudDepartment of Microbiology, Stamford University Bangladesh, Dhaka, Bangladesh.
Joyoshrie KarmakarDepartment of Microbiology, Stamford University Bangladesh, Dhaka, Bangladesh.
Jie FanFaculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, China.
Ishatur NimeKey Laboratory of Environment Correlative Dietology, College of Food Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Mrityunjoy AcharjeeDepartment of Microbiology, Stamford University Bangladesh, Dhaka, Bangladesh.
Fan PanFaculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology (SUAT), No. 1 Gongchang Road, Guangming District, Shenzhen, China.
Md Sharifull IslamCenter for Cancer Immunology, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), 1068 Xueyuan Avenue, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The advancement of synthetic biology and the rise of antimicrobial resistance have led to the development of bacteriophage therapy for more than antibacterial applications. This review focuses on applications to multidrug-resistant infections, biofilm diseases, cancer research, veterinary medicine and animal production. Recent research suggests phages can be used in combination with antibiotics to enhance treatment of large multidrug resistant pathogens such as

Indexed as

Bacterial InfectionsBacteriophagesPhage TherapyAnimalsAnti-Bacterial AgentsBiofilmsDrug Resistance, Multiple, BacterialHumansNeoplasmsAnti-Bacterial Agentsantimicrobial resistancebacteriophage therapybiofilm eradicationpersonalized medicinephage antibiotic synergy

Identifiers

PMID42488416
PMCPMC13388074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.